Skip to main content
Medacta Group SA logo

Medacta Group SA — Investor Relations & Filings

Ticker · MOVE ISIN · CH0468525222 LEI · 506700P2PFU3A3DROC14 SW Manufacturing
Open in API
Filings indexed 197 across all filing types
Latest filing 2024-02-12 Regulatory Filings
Country CH Switzerland
Listing SW MOVE

About Medacta Group SA

https://www.medacta.com/

Medacta Group SA is a medical device company that designs, manufactures, and distributes orthopaedic and neurosurgical products worldwide. Its portfolio focuses on joint replacement, spine surgery, and sports medicine. The company emphasizes innovation in minimally invasive surgical techniques and personalized patient solutions, developed through close collaboration with surgeons. A key component of its business model is the M.O.R.E. Institute, a global medical education platform that provides comprehensive training and support for healthcare professionals. Medacta is recognized for pioneering advanced surgical approaches, such as Kinematic Alignment for total knee replacement, with a focus on improving patient outcomes and healthcare sustainability.

Recent filings

Filing Released Lang Actions
Medacta to Feature GMK SpheriKA and Innovative Personalized Solutions at AAOS 2024
Regulatory Filings Classification · 1% confidence The document is a 'MEDIA RELEASE' dated February 12, 2024, announcing Medacta Group SA's participation in the AAOS 2024 meeting and highlighting new product features (GMK SpheriKA, NextAR). It is a general corporate announcement about product promotion and industry participation, not a mandatory financial filing like a 10-K, an earnings release (ER), or a specific regulatory report (AR, IR, etc.). Since it is a general corporate announcement distributed via a news service (EQS News Service), and it doesn't fit the specific categories like Director's Dealing (DIRS), Dividend Notice (DIV), or Capital Change (CAP), the most appropriate general category is Regulatory Filings (RNS), which serves as the fallback for miscellaneous corporate news releases that are not otherwise classified.
2024-02-12 English
Medacta to Feature GMK SpheriKA and Innovative Personalized Solutions at AAOS 2024
Report Publication Announcement Classification · 1% confidence The document is titled 'MEDIA RELEASE' and announces the company's participation in an industry event (AAOS 2024) to showcase new products (GMK SpheriKA, NextAR). It contains standard press release formatting, contact information, and boilerplate 'ABOUT' sections. This structure strongly indicates a general corporate announcement intended for the media and investors, rather than a formal regulatory filing like a 10-K, IR, or ER. Since it is a general announcement about company activities and product promotion, and does not fit the specific categories like Dividend (DIV), Director Dealing (DIRS), or Capital Change (CAP), the most appropriate classification is the general regulatory announcement fallback category, RNS (Regulatory Filings), as it is a public disclosure. However, given the content is purely promotional/informational about participation in a conference and product features, and not a mandatory financial filing, it aligns best with a general corporate news release. In the provided schema, RNS serves as the miscellaneous/fallback category for regulatory announcements that don't fit elsewhere. Since the document length is substantial (6651 chars) and it is a full release, it is not an RPA.
2024-02-12 English
Medacta Group SA: Medacta Group SA revenues up +19.5% at constant currency1 exceeding the milestone of 500Mln in FY 2023
Earnings Release Classification · 1% confidence The document is titled 'Medacta Group SA revenues up +19.5% at constant currency1 exceeding the milestone of 500Mln € in FY 2023' and is explicitly labeled as an 'Ad-hoc' announcement and 'Press Release – Ad-hoc announcement pursuant to Art. 53 LR'. It provides preliminary, unaudited revenue figures for the full year 2023 (FY 2023) and announces a future date (March 13, 2024) for the announcement of the '2023 Full Year Results'. This structure—releasing key preliminary financial highlights ahead of the official, comprehensive report—is characteristic of an Earnings Release (ER). It is not the full Annual Report (10-K) or the comprehensive Interim Report (IR), but the initial announcement of results. FY 2023
2024-02-02 English
Medacta Group SA: Medacta Group SA revenues up +19.5% at constant currency1 exceeding the milestone of 500Mln € in FY 2023
Earnings Release Classification · 1% confidence The document is titled 'Ad hoc announcement pursuant to Art. 53 LR' and explicitly states it is a 'Press Release – Ad-hoc announcement pursuant to Art. 53 LR'. It provides preliminary, unaudited revenue figures for the full year 2023 (FY 2023) and announces a webcast to discuss these figures today. Crucially, it states: 'The Company will announce its 2023 Full Year Results on 13 March 2024.' This indicates the current document is an early release of key financial highlights (revenue performance) before the comprehensive official report (which would likely be a 10-K or IR). This structure—a brief, high-level announcement of period results with a future date for the full results—is characteristic of an Earnings Release (ER). It is not the full Annual Report (10-K) or the comprehensive Interim Report (IR), nor is it merely an announcement of a report publication (RPA), as it contains the actual preliminary results. FY 2023
2024-02-02 English
Medactas QUADRA-H hip stem achieves 13A* exemplary quality rating from the British Orthopaedic Data Evaluation Panel (ODEP)
Regulatory Filings Classification · 1% confidence The document is a 'MEDIA RELEASE' dated January 8, 2024, announcing a specific achievement: Medacta's QUADRA-H hip stem received a 13A* exemplary quality rating from the British Orthopaedic Data Evaluation Panel (ODEP). It contains company news, product details, quotes, and contact information, typical of a press release regarding a corporate event or achievement. Since it is an announcement of a specific, non-financial regulatory/industry rating achievement, and not a standard periodic financial report (10-K, IR, ER, MRQ), nor a general regulatory filing (RNS), it best fits the category for general corporate news that doesn't fit other specific financial/governance codes. Given the options, 'Regulatory Filings' (RNS) is the most appropriate fallback for a specific, non-standard corporate announcement that isn't a management change (MANG) or a financing event (CAP). However, upon reviewing the definitions, this is a specific operational/product achievement announcement. Since there is no specific code for 'Product Achievement Announcement', and it is not a standard financial report, it falls under the general regulatory announcement category, RNS, as a catch-all for non-standard corporate news releases.
2024-01-08 English
Medacta’s QUADRA-H hip stem achieves 13A* exemplary quality rating from the British Orthopaedic Data Evaluation Panel (ODEP)
Regulatory Filings Classification · 1% confidence The document is explicitly labeled as a "MEDIA RELEASE" and announces a specific operational achievement (a medical implant receiving a quality rating from an independent panel, ODEP). It is dated and includes contact information for media inquiries. This format is characteristic of a general corporate announcement or press release that does not fit into the specific financial reporting categories (like 10-K, ER, IR, or DIV). Since it is a general, non-mandatory regulatory announcement, the most appropriate fallback category is Regulatory Filings (RNS), as it serves as a general public disclosure.
2024-01-08 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.